1 |
Verhoef V, Visser O, de Man RA, et al (2004). Hepatocellular carcinoma in the Netherlands incidence, treatment and survival patterns. Eur J Cancer, 40, 1530-8.
DOI
ScienceOn
|
2 |
Wong R, Corley DA (2008). Racial and ethnic variations in hepatocellular carcinoma incidence within the United States. Am J Med, 121, 525-31.
DOI
ScienceOn
|
3 |
Yusuf MA, Badar F, Meerza F, et al (2007). Survival from hepatocellular carcinoma at a cancer hospital in Pakistan. Asian Pac J Cancer Prev, 8, 272-4.
|
4 |
Zainal AO, Nor Saleha IT (2011). National Cancer Registry Report. Malaysia Cancer Statistics- Data and Figure 2007. National Cancer Registry, Ministry of Health Malaysia: Kuala Lumpur.
|
5 |
Zhou XD, Tang ZY, Yang BH, Zhang BH (2000). Hepatocellular carcinoma: the role of screening. Asian Pac J Cancer Prev, 1, 121-6.
|
6 |
Befeler AS, Di Bisceglie AM (2002). Hepatoellular carcinoma: diagnosis and treatment. Gastroenterol, 122, 1609-19.
DOI
ScienceOn
|
7 |
Bosch FX, Ribes J, Diaz M, Cleries R (2004). Primary liver cancer: worldwide incidence and trends. Gatroenterol, 127, 5-16.
DOI
|
8 |
Bruix J, Llovet JM (2002). Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatol, 35, 519-24.
DOI
ScienceOn
|
9 |
Bruix J, Sherman M, Llovet JM, et al (2001). Clinical management of hepatocellular carcinoma.Conclusions of the Barcelona-2000 EASL Conference. J Hepatol, 35, 421-30.
DOI
ScienceOn
|
10 |
Chen CJ, Yu MW, Liaw YF (1997). Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol, 12, 294-308.
DOI
ScienceOn
|
11 |
Deuffic S, Poynard T, Buffat L, Valleron AJ (1998). Trends in primary liver cancer. Lancet, 351, 214-5.
|
12 |
El-Serag H, Rudolf L (2007). Reviews in basic and clinical gastroenterology. Gastroenterol, 132, 2557-76.
DOI
ScienceOn
|
13 |
El-Serag HB, Davila JA, Petersen NJ, McGlynn KA (2003). The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med, 139, 817-23.
DOI
ScienceOn
|
14 |
Gao J, Xie L, Yang WS, et al (2012). Risk factors of hepatocellular carcinoma - current status and perspectives. Asian Pac J Cancer Prev, 13, 743-52.
DOI
ScienceOn
|
15 |
Groen KA (1999). Primary and metastatic liver cancer. Sem Oncol Nurs, 15, 48-57.
DOI
ScienceOn
|
16 |
Hasegawa K, Kokudo N (2009). Surgical treatment of hepatocellular carcinoma. Surg Today, 39, 833-43.
DOI
|
17 |
Kansa-ard S, Wiangnon S, Suwanrungruang K, et al (2011). Trends in liver cancer incidence between 1985 and 2009, Khon Kaen, Thailand: cholagiocarcinoma. Asian Pac J Cancer Prev, 12, 2209-13.
|
18 |
Llovet JM, Real MI, Montana X, et al (2002). Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet, 359, 1734-9.
DOI
ScienceOn
|
19 |
Nordenstedt H, White DL, El-Serag HB (2010).The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis, 42, 206-14.
DOI
ScienceOn
|
20 |
Nguyen VTT, Law MG, Dore GJ (2009). Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden. J Virus Hepatitis, 16, 453-63.
DOI
ScienceOn
|
21 |
Okuda K, Ohtsuki T, Obata H, et al (1985). Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patients. Cancer, 56, 918-28.
DOI
|
22 |
Sangro B, Herraiz M, Martinez-Gonzalez MA, et al (1998). Prognosis of hepatocellular carcinoma in relation to treatment: a multivariate analysis of 178 patients from a single European institution. Surg, 124, 575-83.
DOI
ScienceOn
|
23 |
Siegel R, Ward E, Brawley O, Jemal A (2011). Cancer statistics, 2011. The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin, 61, 212-36.
DOI
|
24 |
Soong RS, Yu MC, Chan KM, et al (2011). Analysis of the recurrence risk factors for the patients with hepatocellular carcinoma meeting University of California San Francisco criteria after curative hepatectomy. World J Surg Oncol, 9, 9.
DOI
ScienceOn
|
25 |
Srivatanakul P, Sriplung H, Deerasamee S (2004). Epidemiology of liver cancer: an overview. Asian Pac J Cancer Prev, 5, 118-25.
|
26 |
Takano S, Watanabe Y, Ohishi H, et al (2000). Multinodality treatment for patients with hepatocellular carcinoma: a single institution retrospective series. Eur J Surg Oncol, 26, 67-72.
DOI
ScienceOn
|
27 |
Teo EK, Fock KM (2001). Hepatocellular carcinoma: an Asian perspective. Dig Dis, 19, 263-8.
DOI
ScienceOn
|
28 |
Trevisani F, D’Intino PE, Grazi GL, et al (1996). Clinical and pathologic features of hepatocellular carcinoma in young and olderItalian patients. Cancer, 77, 2223-32.
DOI
|